Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Alfredo Zito"'
Autor:
Maria Colomba Comes, Livia Fucci, Sabino Strippoli, Samantha Bove, Gerardo Cazzato, Carmen Colangiuli, Ivana De Risi, Ileana De Roma, Annarita Fanizzi, Fabio Mele, Maurizio Ressa, Concetta Saponaro, Clara Soranno, Rosita Tinelli, Michele Guida, Alfredo Zito, Raffaella Massafra
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Risk stratification and treatment benefit prediction models are urgent to improve negative sentinel lymph node (SLN-) melanoma patient selection, thus avoiding costly and toxic treatments in patients at low risk of recurrence. To
Externí odkaz:
https://doaj.org/article/95ad4c7525344afab6eec62c16a1a0f7
Autor:
Annarita Fanizzi, Domenico Pomarico, Alessandro Rizzo, Samantha Bove, Maria Colomba Comes, Vittorio Didonna, Francesco Giotta, Daniele La Forgia, Agnese Latorre, Maria Irene Pastena, Nicole Petruzzellis, Lucia Rinaldi, Pasquale Tamborra, Alfredo Zito, Vito Lorusso, Raffaella Massafra
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract For endocrine-positive Her2 negative breast cancer patients at an early stage, the benefit of adding chemotherapy to adjuvant endocrine therapy is not still confirmed. Several genomic tests are available on the market but are very expensive.
Externí odkaz:
https://doaj.org/article/b56ee393ea0943caa915c1041b0d325d
Autor:
Maria Colomba Comes, Livia Fucci, Fabio Mele, Samantha Bove, Cristian Cristofaro, Ivana De Risi, Annarita Fanizzi, Martina Milella, Sabino Strippoli, Alfredo Zito, Michele Guida, Raffaella Massafra
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract The application of deep learning on whole-slide histological images (WSIs) can reveal insights for clinical and basic tumor science investigations. Finding quantitative imaging biomarkers from WSIs directly for the prediction of disease-free
Externí odkaz:
https://doaj.org/article/79ab25ca515d423ea61cbbe39ed05d5e
Autor:
Samantha Bove, Maria Colomba Comes, Vito Lorusso, Cristian Cristofaro, Vittorio Didonna, Gianluca Gatta, Francesco Giotta, Daniele La Forgia, Agnese Latorre, Maria Irene Pastena, Nicole Petruzzellis, Domenico Pomarico, Lucia Rinaldi, Pasquale Tamborra, Alfredo Zito, Annarita Fanizzi, Raffaella Massafra
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract In breast cancer patients, an accurate detection of the axillary lymph node metastasis status is essential for reducing distant metastasis occurrence probabilities. In case of patients resulted negative at both clinical and instrumental exam
Externí odkaz:
https://doaj.org/article/21667fa02e724bf7860830faad46bc80
Autor:
Raffaella Massafra, Annarita Fanizzi, Nicola Amoroso, Samantha Bove, Maria Colomba Comes, Domenico Pomarico, Vittorio Didonna, Sergio Diotaiuti, Luisa Galati, Francesco Giotta, Daniele La Forgia, Agnese Latorre, Angela Lombardi, Annalisa Nardone, Maria Irene Pastena, Cosmo Maurizio Ressa, Lucia Rinaldi, Pasquale Tamborra, Alfredo Zito, Angelo Virgilio Paradiso, Roberto Bellotti, Vito Lorusso
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionRecently, accurate machine learning and deep learning approaches have been dedicated to the investigation of breast cancer invasive disease events (IDEs), such as recurrence, contralateral and second cancers. However, such approaches are
Externí odkaz:
https://doaj.org/article/6a6b097c0dac4ec68f7e132a2023c0ef
Autor:
Annalisa Schirizzi, Aram Arshadi, Doron Tolomeo, Laura Schirosi, Anna Maria Valentini, Giampiero De Leonardis, Maria Grazia Refolo, Rossella Donghia, Clelia Tiziana Storlazzi, Alfredo Zito, Angela Dalia Ricci, Simona Vallarelli, Carmela Ostuni, Maria Bencivenga, Giovanni De Manzoni, Caterina Messa, Raffaele Armentano, Gianluigi Giannelli, Claudio Lotesoriere, Rosalba D’Alessandro
Publikováno v:
Biomedicines, Vol 11, Iss 10, p 2721 (2023)
Metastatic gastric cancer (mGC) often has a poor prognosis and may benefit from a few targeted therapies. Ramucirumab-based anti-angiogenic therapy targeting the VEGFR2 represents a milestone in the second-line treatment of mGC. Several studies on di
Externí odkaz:
https://doaj.org/article/4e8a709cb37c4383a6a564c6da1935bb
Autor:
Annarita Fanizzi, Giovanni Scognamillo, Alessandra Nestola, Santa Bambace, Samantha Bove, Maria Colomba Comes, Cristian Cristofaro, Vittorio Didonna, Alessia Di Rito, Angelo Errico, Loredana Palermo, Pasquale Tamborra, Michele Troiano, Salvatore Parisi, Rossella Villani, Alfredo Zito, Marco Lioce, Raffaella Massafra
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/1fd6c4bcbe6c4153aec24bf6bdf2ce8d
Autor:
Annarita Fanizzi, Giovanni Scognamillo, Alessandra Nestola, Santa Bambace, Samantha Bove, Maria Colomba Comes, Cristian Cristofaro, Vittorio Didonna, Alessia Di Rito, Angelo Errico, Loredana Palermo, Pasquale Tamborra, Michele Troiano, Salvatore Parisi, Rossella Villani, Alfredo Zito, Marco Lioce, Raffaella Massafra
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Background and purposeAlthough the latest breakthroughs in radiotherapy (RT) techniques have led to a decrease in adverse event rates, these techniques are still associated with substantial toxicity, including xerostomia. Imaging biomarkers could be
Externí odkaz:
https://doaj.org/article/315f385a0a2c409c85448f891a5abfd4
Autor:
Alessandro Rizzo MD, Antonio Cusmai MD, Raffaella Massafra PhD, Samantha Bove PhD, Maria Colomba Comes PhD, Annarita Fanizzi PhD, Gennaro Gadaleta-Caldarola MD, Donato Oreste MD, Alfredo Zito MD, Francesco Giotta MD, Vito Lorusso MD, Gennaro Palmiotti MD
Publikováno v:
Cancer Control, Vol 29 (2022)
Epidermal growth factor receptor 2 (EGFR2, also known as HER2) overexpression and/or amplification confers a more aggressive clinical behavior but also represents a therapeutic opportunity for targeted therapies in breast cancer (BC). Over the last 2
Externí odkaz:
https://doaj.org/article/360c03889f5c4df8bfe1bc8d24c80f02
Autor:
Raffaella Massafra, Maria Colomba Comes, Samantha Bove, Vittorio Didonna, Sergio Diotaiuti, Francesco Giotta, Agnese Latorre, Daniele La Forgia, Annalisa Nardone, Domenico Pomarico, Cosmo Maurizio Ressa, Alessandro Rizzo, Pasquale Tamborra, Alfredo Zito, Vito Lorusso, Annarita Fanizzi
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Designing targeted treatments for breast cancer patients after primary tumor removal is necessary to prevent the occurrence of invasive disease events (IDEs), such as recurrence, metastasis, contralateral and second tumors, over time. However, due to
Externí odkaz:
https://doaj.org/article/34c8dae740bc4a88815b1d824d804eb6